Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Evolus, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 130 | 1 | 120 | −9 |
| Shares | 25.6M | 192 | 29.3M | +3.71M (+14.5%) |
| Value | $205.7M | $2.00K | $219.8M | +$14.1M (+6.8%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Evolus, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caligan Partners LP | 1,740,700 | $13.1M | 10.88% |
| Eversept Partners, LP | 713,774 | $5.36M | 0.51% |
| Jefferies Financial Group Inc. | 500,030 | $3.76M | 0.06% |
| Great Point Partners LLC | 190,329 | $1.43M | 0.30% |
| Brandywine Global Investment Management, LLC | 155,900 | $1.17M | 0.01% |
| Renaissance Technologies LLC | 91,300 | $686.0K | 0.00% |
| Legato Capital Management LLC | 75,579 | $567.6K | 0.11% |
| Pura Vida Investments, LLC | 50,000 | $375.5K | 0.06% |
| Cetera Advisors LLC | 27,768 | $208.5K | 0.00% |
| Two Sigma Investments, LP | 18,656 | $140.1K | 0.00% |
| Fox Run Management, L.L.C. | 10,864 | $81.6K | 0.03% |
| Arizona State Retirement System | 10,288 | $77.3K | 0.00% |
| Washington Trust Co | 10,000 | $75.1K | 0.00% |
| Point72 Middle East FZE | 5,244 | $39.4K | 0.00% |
| Balyasny Asset Management LLC | 2,284 | $17.2K | 0.00% |
| Advisory Services Network, LLC | 1,122 | $8.43K | 0.00% |
| GWM Advisors LLC | 234 | $2 | 0.00% |
| Sofos Investments, Inc. | 8 | $1 | 0.00% |
| VitalStone Financial, LLC | 30 | $0 | 0.00% |
Sold out (28)
Institutions that held Evolus, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (1)
Institutions that held Evolus, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 192 | $2.00K |